Testosterone Attorneys at Bernstein Liebhard LLP Comment on Report Questioning Risks and Benefits of Low Testosterone Therapy

Share Article

The publication of the report comes a little over a year since federal regulators launched a safety review to better assess the cardiovascular risks potentially associated with prescription low testosterone therapies.

Free Case Review
The publication of this report comes a little more than a year after the FDA launched a safety review to better assess the potential for heart complications related to the use of prescription testosterone treatments.

The testosterone attorneys (http://www.testosteronelawsuithub.com/testosterone-lawyer/) at Bernstein Liebhard LLP note the publication of a new report that questions the risks and benefits associated with prescription medications used to treat low testosterone in men. The article, which was published by U.S. News & World Report on February 6th, asserts that low testosterone is a far more complex condition than what is presented in much of the advertising used to drive sales of testosterone treatments. The report also pointed to a need for larger studies investigating the cardiovascular risks that may be associated with these drugs, as studies conducted thus far have produced conflicting findings.*

“The publication of this report comes a little more than a year after the FDA launched a safety review to better assess the potential for heart complications related to the use of prescription testosterone treatments. It should also be noted that in September, a panel of agency advisors also recommended that the drugs be subjected to further research to better understand these risks,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices.** The Firm is representing men who allegedly suffered serious cardiovascular problems due to their use of low testosterone therapy, and continues to offer free case reviews to those who may have been harmed by prescription testosterone products.

Testosterone Heart Risks
The U.S. Food & Drug Administration announced its safety review of low testosterone treatments on January 31, 2014, after two studies tied the medications to an increased risk of heart attack, stroke and death in certain men. One of these studies reported that such treatments ware associated with a doubling of the heart attack risk among younger men with pre-existing heart problems, and in men over 65 regardless of their heart health. Another suggested an increased risk of heart attack, stroke and death among older men with pre-existing heart problems, the agency said.

In September, a panel of FDA advisors recommended that labeling on testosterone medications be adjusted to make clear their lack of proven effectiveness in treating low libido, fatigue, muscle loss and other symptoms men often experience as they age. Panelists also urged FDA to require manufacturers of testosterone replacement therapies to conduct large-scale studies of their cardiovascular side effects.**

Since the FDA launched its testosterone review last year, court records indicate that hundreds of testosterone lawsuits have been filed n a federal multidistrict litigation now underway in U.S. District Court, Northern District of Illinois. All of the claims pending in the proceeding were brought on behalf of men who allegedly experienced heart attacks, strokes, blood clots, and other cardiovascular problems due to their use of these medications. Among other things, these lawsuits accuse drug manufacturers of failing to adequately warn about the alleged association between testosterone replacement therapy and life-threatening heart complications. Plaintiffs further accuse the companies of concealing information about these side effects, and claim that misleading marketing tactics were used to promote the medications to patients who had no real medical need for testosterone treatment (In re: Testosterone Replacement Therapy Product Liability Litigation - MDL No. 2545)

Men who allegedly suffered serious cardiovascular events due to their use of prescription testosterone treatments may be entitled to compensation for their injury-related damages. To learn more about filing a testosterone treatment lawsuit, please visit Bernstein Liebhard LLP's website. Free, no-obligation legal consultations can be obtained by calling 800-511-5092.

*health.usnews.com/health-news/patient-advice/articles/2015/02/06/treating-low-testosterone-weighing-risks-and-benefits, US News & World Report, February 6, 2015
**reuters.com/article/2014/09/17/us-usa-health-testosterone-idUSKBN0HC2C320140917, Reuters, September 17, 2014

About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs' Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.

Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016

ATTORNEY ADVERTISING. © 2015 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Contact Information:
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Felecia L. Stern
Follow us on
Visit website